Status:
UNKNOWN
Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Lung Diseases, Interstitial
Lung Disease With Systemic Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Interstitial lung diseases (ILDs) are a heterogeneous group of disorders, which encompass a wide range of conditions. In some patients with fibrosing ILDs, a progressive phenotype similar to that obse...
Eligibility Criteria
Inclusion
- Patients hospitalized for PF-ILD and SSc-ILD in France between 01/01/2010 and 31/12/2017
- Men or women aged ≥ 18 years old at diagnosis
Exclusion
- Patients treated by anti-fibrotic
- Patients diagnosed with IPF
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03858842
Start Date
March 1 2019
End Date
December 1 2019
Last Update
March 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Cardiologique Louis Pradel
Bron, France